A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 69
Healthy Volunteers: t
View:
• good general health
Locations
Other Locations
Australia
University of Adelaide Clinical Research Facility
RECRUITING
Adelaide
Contact Information
Primary
Nerissa Lakhan, PhD
nerissa@gpnvaccines.com
+61-432 161 783
Backup
Paul E Rolan, MD
paul@gpnvaccines.com
+61-405 670 420
Time Frame
Start Date: 2025-10
Estimated Completion Date: 2026-06
Participants
Target number of participants: 12
Treatments
Experimental: Gamma -PN
Intramuscular administration 500 mcg
Related Therapeutic Areas
Sponsors
Leads: GPN Vaccines